Flavia Neto de Jesus | Molecular Mechanisms Signaling | Best Research Article Award

Dr. Flavia Neto de Jesus | Molecular Mechanisms Signaling | Best Research Article Award

Dr. Flavia Neto de Jesus, Texas A&M University, United States

Dr. Flavia Neto de Jesus is a passionate research scientist with a PhD in Pharmacology from the University of São Paulo and over a decade of experience in preclinical and translational research. She specializes in inflammation, reactive oxygen species (ROS), vascular physiology, and lymphatic system disorders, particularly in the context of arthritis and cancer. Currently a Postdoctoral Researcher in Canada, Dr. de Jesus has developed extensive skills in molecular biology, vascular imaging, and functional assays. Her multidisciplinary research contributes to advancing knowledge in immunopathology, lymphatic remodeling, and endothelial function. Widely published and recognized in her field, she has received awards for her scientific contributions and actively mentors students and collaborates across diverse research teams. Her work bridges pharmacological mechanisms with clinically relevant models, demonstrating both scientific rigor and innovation.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Originality & Scientific Merit:
    Dr. de Jesus’s work on lymphatic physiology, inflammation, and reactive oxygen species stands out for its mechanistic depth and translational relevance. Her findings related to NOX inhibition, acetylcholine-mediated vasodilation, and lymphatic hyperactivity in arthritis present novel therapeutic insights.

  2. High-Impact Publications:
    Published in respected journals such as PNAS, Life Sciences, Antioxidants, Biomolecules, and Microcirculation, her research demonstrates a consistent track record of scientific excellence.

  3. Award-Winning Contribution:
    The 2023 Travel Award from the Lymphatic Forum for a detailed vascular-laboratory-based study highlights peer recognition and confirms the value of her contributions to lymphatic research.

  4. Advanced Methodology:
    She applies cutting-edge techniques in animal models, functional vascular assessments, and molecular biology—key components that strengthen the scientific rigor of her articles.

  5. Interdisciplinary Relevance:
    Her research links vascular biology, immunology, and pharmacology, adding significant value across disciplines including rheumatology, oncology, and metabolic disease.

⚠️ Areas for Improvement:

  1. Pending Publications:
    A few of her strongest recent manuscripts are still under review or in preparation. Their final publication would bolster her visibility and add further weight to her candidacy.

  2. Broader International Outreach:
    While her collaborations are robust, engaging more with international institutions beyond North and South America could further amplify the global impact of her work.

  3. Clear Highlight of Novelty in Abstracts:
    While the research is rich in content, abstracts and titles could more clearly emphasize novelty and real-world implications to stand out for award nominations.

🎓 Education:

Dr. Flavia Neto de Jesus earned her PhD in Pharmacology from the University of São Paulo, one of Brazil’s premier institutions for biomedical research. During her graduate studies (2011–2019), she focused on vascular biology and inflammation, developing deep expertise in endothelial dysfunction, nitric oxide signaling, and lymphatic-arterial cross-regulation. Her early academic journey included foundational studies in biology and pharmacological techniques, enriched by rigorous laboratory practice and collaborative research. To complement her ethical and methodological framework, she completed the TCPS2 training (Ethical Conduct for Research Involving Humans) in 2024 in Calgary, Canada. This has enabled her to work seamlessly in both Brazilian and Canadian research environments. Her education reflects a strong grounding in both experimental and translational science, empowering her to contribute meaningfully to complex biomedical challenges.

🧪 Professional Experience:

Since April 2019, Dr. Flavia Neto de Jesus has been working as a Postdoctoral Researcher focusing on inflammation-related mechanisms in arthritis, fibrosis, and cancer-associated lymphatic changes. Her role encompasses designing and executing in vivo studies, molecular biology experiments, and vascular function assessments. She leads laboratory operations, supervises student researchers, and contributes significantly to manuscript development and conference presentations. Her contributions to the field include pioneering insights into lymphatic dysfunction, ROS involvement in vascular remodeling, and endothelial channel regulation. With over a decade in pharmacological research, Dr. de Jesus has cultivated a rich portfolio of publications and collaborations across interdisciplinary teams. Her experience reflects a strong command over both experimental methodology and collaborative science, making her a valuable contributor in both academic and applied research settings.

🏅 Awards and Honors:

Dr. Flavia Neto de Jesus has been recognized for her significant contributions to lymphatic system research. Notably, she received the Travel Award in 2023 from the Lymphatic Forum Conference for her impactful abstract: “Decreased contraction frequency by NOX inhibition and ACh-mediated vasodilation in hyperactive popliteal afferent lymphatic vessels in a TNFα-induced spontaneous arthritis mouse model.” This award acknowledged her advanced understanding of vascular and immune interplay in chronic inflammation. Additionally, she has participated in prestigious international conferences, such as the 19th World Congress of Basic & Clinical Pharmacology, where her work on NOS and NOX regulation in lymphatics was presented. These honors reflect her growing recognition within the vascular biology and pharmacology communities, underscoring her potential as a leader in translational immunovascular research.

🔬 Research Focus:

Dr. de Jesus’s research focuses on the interplay between inflammation, oxidative stress, and vascular dysfunction—especially within the context of the lymphatic system. Her work investigates how reactive oxygen species (ROS), nitric oxide signaling, and molecular pathways like NADH oxidase (NOX) and endothelin (ET) regulate lymphatic vessel contractility and remodeling. Her current postdoctoral work explores lymph node immunobiology, arthritis models, and cancer-lymphatic interactions using sophisticated in vivo and molecular approaches. She integrates vascular physiology with immunology, seeking to unravel how inflammation alters lymphatic transport, immune cell trafficking, and endothelial responses. Her studies often leverage genetically modified mouse models and combine functional assays with histological, biochemical, and transcriptomic analyses. Dr. de Jesus’s research offers novel insights into pathophysiological processes underlying chronic diseases such as arthritis, fibrosis, and cancer, positioning her at the forefront of lymphovascular research.

📚 Publications Top Notes:

📖 Hyperactive popliteal lymphatic vessels require activation of NADH oxidase (NOX) and endothelin (ET) pathways in arthritic mice (In prep)
📖 Microbiota is dispensable for lymphatic vessel hyperactivity in the TNFΔARE/+ mouse modelArthritis Rheumatology (Under revision)
📖 Dysregulated lymphatic remodeling promotes immunopathology during non-healing cutaneous leishmaniasisCell Press (Under review)
📖 Presence of dysfunctional soluble guanylate cyclase in mesenteric arteries from periodontitis ratsEuropean J. of Pharmacology (2025)
📖 Flow-dependent regulation of mesenteric lymphatic vessels via TRPV4 activationMicrocirculation (2023)
📖 Increased contractile activity and dilation of lymphatic vessels in TNF-α-overexpressing arthritic miceLife Sciences (2023)
📖 Lymph-derived chemokines drive neutrophil infiltration in lymph nodes post-S. aureus infectionPNAS (2022)
📖 Nutraceutical mix modulates gene expression in Type-2 Diabetes Obesity ModelAntioxidants (2022)
📖 AP39-induced vasorelaxation in mouse mesenteric arteriesBiomolecules (2022)
📖 Leukotriene receptor antagonist reduces bone loss in periodontitisJournal of Periodontology (2021)
📖 Endothelial dysfunction in periodontitis involves NO and COX-2 productsArchives of Oral Biology (2016)
📖 Beta-alanine and sodium bicarbonate improve swimming performanceApplied Physiology, Nutrition, and Metabolism (2013)

📝 Conclusion:

Dr. Flavia Neto de Jesus is highly suitable for the Best Research Article Award. Her article on NOX inhibition and ACh-mediated vasodilation in hyperactive lymphatic vessels offers a novel mechanistic insight into the vascular pathology of inflammatory arthritis, an area with significant unmet clinical need. Her work is original, methodologically rigorous, and impactful within the field of lymphatic and vascular biology. Given her award-winning presentation, peer-reviewed track record, and interdisciplinary research value, she is a strong candidate deserving of recognition.

Trilochan Satapathy | Pharmacology | Best Researcher Award

Prof Dr Trilochan Satapathy |  Pharmacology |  Best Researcher Award

Professor at  Columbia Institute of Pharmacy, India

Dr. Trilochan Satapathy, an esteemed academic and professional in the field of Pharmacy, hails from Raisunguda, Odisha, and is currently based in Raipur, Chhattisgarh. He holds a D.Sc. in Pharmacy from Berhampur University (2020) and a Ph.D. in Pharmacy from Utkal University (2012). Additionally, he completed an MBA in Educational Management from Alagappa University (2012), an M.Pharm in Pharmacology from K.L.E.S’s College of Pharmacy (2007), a B.Pharm from I.P.T. Salipur (1999), and a D.Pharm from I.P.T. Salipur (1993).

Profile

Educational Qualifications:

🎓 D.Sc (Pharmacy) – Berhampur University, Odisha (2020)
🎓 PhD (Pharmacy) – Utkal University, Bhubaneswar, Odisha (2012)
🎓 M.B.A (Education Management) – Alagappa University, Tamil Nadu, India (2012)
🎓 M.Pharm (Pharmacology) – K.L.E.S’S. College of Pharmacy, Karnataka (2007)
🎓 B.Pharm – I.P.T. Salipur, Utkal University, Odisha (1999)
🎓 D.Pharm – I.P.T., Salipur, Odisha State Board of Pharmacy, Odisha (1993)

Professional Experience:

  • Clinical Pharmacist – Dr. K M Nayak (1993-1995)
  • Senior Lecturer – I.P.S.T.P. Cuttack, Odisha (2000-2007)
  • Vice-Principal – I.P.S.T.P. Cuttack, Odisha (2007-2008)
  • Assistant Professor – K.M.I.P.S., Rourkela, Odisha (2008-2010)
  • Associate Professor and HOD – CIP, Raipur, Chhattisgarh (2010-2017)
  • Professor and HOD – CIP, Raipur, Chhattisgarh (2017-2019)
  • Principal and Professor – RITEE College of Pharmacy, Chhattisgarh (2019-2020)
  • Professor – UCOP Raipur (CSVTU), Chhattisgarh (2020-2023)
  • Professor and HOD – CIP, Raipur, Chhattisgarh (2023-Present)

Achievements:

🏅 Gold Medal in M.Pharm (Pharmacology) – 2007
🏅 Advisory Board Member – Journal of Pharmacology Research (Bio-Info)
🏅 Fellowship Academy of Science (Animal Welfare)
🏅 Fellow Institute of Chemist India (FIC)
🏅 CPCSEA Nominee, Govt. of India
🏅 Member – CSVTU Inspection Team and Board of Studies
🏅 Approved PhD Guide – CSVTU and JJTU, Rajasthan
🏅 Main Nominee – IAEC, Pt. Ravishankar Shukla University, Raipur

Research Focus in Pharmacology:

Dr. Trilochan Satapathy has a profound interest and extensive experience in the field of pharmacology, with a specific focus on the following areas:

  1. Drug Development and Evaluation:
    • Involved in the formulation, testing, and evaluation of new pharmaceutical compounds.
    • Focuses on the development of novel drug delivery systems to improve therapeutic efficacy and patient compliance.
  2. Pharmacokinetics and Pharmacodynamics:
    • Studies the absorption, distribution, metabolism, and excretion (ADME) of drugs.
    • Investigates the effects and mechanisms of action of drugs within the body.
  3. Toxicology:
    • Conducts research on the adverse effects of chemical substances on living organisms.
    • Evaluates the safety and potential toxicological profiles of new drugs.
  4. Neuropharmacology:
    • Explores the effects of drugs on the nervous system.
    • Researches treatments for neurological disorders and diseases, including neurodegenerative conditions.
  5. Cardiovascular Pharmacology:
    • Studies the effects of drugs on the cardiovascular system.
    • Focuses on developing medications for heart diseases, hypertension, and related conditions.
  6. Clinical Pharmacology:
    • Engages in clinical trials to test the efficacy and safety of new drugs.
    • Works on optimizing drug therapy for better clinical outcomes.
  7. Pharmacogenomics:
    • Researches the genetic factors that influence drug response and metabolism.
    • Aims to develop personalized medicine approaches based on individual genetic profiles.
  8. Herbal and Traditional Medicine:
    • Investigates the pharmacological properties of herbal and traditional medicines.
    • Works on integrating traditional remedies with modern pharmacological practices.

Dr. Satapathy’s contributions to pharmacology are evidenced by his numerous publications, presentations, and guidance of postgraduate and doctoral research in these areas. His work has significantly advanced the understanding of drug interactions, safety, and efficacy, ultimately contributing to better healthcare outcomes.

Citations:

  • Total Citations: 632
  • Citations Since 2019: 543
  • h-index: 14
  • h-index Since 2019: 13
  • i10-index: 24
  • i10-index Since 2019: 21

Publication Top Notes:

  • Rheumatoid Arthritis: An Updated Overview of Latest Therapy and Drug Delivery
    D Kesharwani, R Paliwal, T Satapathy, SD Paul
    Journal of Pharmacopuncture, 22 (4), 210 (2019)
  • Role of Liposome in Novel Drug Delivery System
    C Dwivedi, R Sahu, SP Tiwari, T Satapathy, A Roy
    Journal of Drug Delivery and Therapeutics, 4 (2), 116-129 (2014)
  • Amelioration of Lipophilic Compounds in Regards to Bioavailability as Self-Emulsifying Drug Delivery System (SEDDS)
    P Baghel, A Roy, S Verma, T Satapathy, S Bahadur
    Future Journal of Pharmaceutical Sciences, 6, 1-11 (2020)
  • Animal Models for Inflammation: A Review
    G Dhalendra, T Satapathy, A Roy
    Asian Journal of Pharmaceutical Research, 3 (4), 207-212 (2013)
  • Rhipicephalus microplus: A Parasite Threatening Cattle Health and Consequences of Herbal Acaricides for Upliftment of Livelihood of Cattle Rearing Communities in Chhattisgarh
    P Jain, T Satapathy, RK Pandey
    Biocatalysis and Agricultural Biotechnology, 26, 101611 (2020)
  • Past and Future of In-Vitro and In-Vivo Animal Models for Diabetes: A Review
    RP Hemlata Dewangan, Raj Kumar Tiwari, Vikas Sharma, Shiv Shankar Shukla, …
    Indian Journal of Pharmaceutical Education and Research, 51 (Issue 4S), S522 (2017)
  • Rhipicephalus microplus (Acari: Ixodidae): Clinical Safety and Potential Control by Topical Application of Cottonseed Oil (Gossypium sp.) on Cattle
    P Jain, T Satapathy, RK Pandey
    Experimental Parasitology, 219, 108017 (2020)
  • Efficacy of Arecoline Hydrobromide Against Cattle Tick Rhipicephalus (Boophilus) microplus
    P Jain, T Satapathy, RK Pandey
    International Journal of Acarology, 46 (4), 268-275 (2020)
  • Evaluation of Anti-GERD Activity of Gastro Retentive Drug Delivery System of Itopride Hydrochloride
    T Satapathy, PK Panda, AK Goyal, G Rath
    Artificial Cells, Blood Substitutes, and Biotechnology, 38 (4), 200-207 (2010)
  • The Exploring of Current Development Status and the Unusual Symptoms of Coronavirus Pandemic (Covid-19)
    V Dewangan, R Sahu, T Satapathy, A Roy
    Research Journal of Pharmacology and Pharmacodynamics, 12 (4), 172-176 (2020)
  • First Report on Ticks (Acari: Ixodidae) Controlling Activity of Cottonseed Oil (Gossypium Sp.)
    P Jain, T Satapathy, RK Pandey
    International Journal of Acarology, 46 (4), 263-267 (2020)
  • A Mini Review of Methods to Control Ticks Population Infesting Cattle in Chhattisgarh with Special Emphasis on Herbal Acaricides
    P Jain, T Satapathy, RK Pandey
    NISCAIR-CSIR, India (2020)
  • Martynia annua: An Overview
    R Kenwat, P Prasad, T Satapathy, A Roy
    Pharmaceutical and Biosciences Journal, 07-10 (2013)
  • Hepatoprotective Activity of Isolated Herbal Compounds
    PJ Premlata Rathore, S. Prakash Rao, Amit Roy, Trilochan Satapathy, Vijay Singh
    Research Journal of Pharmacy and Technology, 7 (02), 229-234 (2014)
  • Indian Herbal Medicines Used for Treatment of Dementia: An Overview
    C Dwivedi, K Chandrakar, V Singh, SP Tiwari, T Satapathy, S Kesharwani, …
    International Journal of Pharmacognosy, 1 (9), 353-371 (2014)
  • A Review on Ethnopharmacological Approaches to Wound Healing and Curative Progression
    AK Netam, J Prasad, T Satapathy
    Research Journal of Pharmacology and Pharmacodynamics, 11 (1), 37-45 (2019)
  • Development, QbD Based Optimization and In Vitro Characterization of Diacerein Loaded Nanostructured Lipid Carriers for Topical Applications
    D Kesharwani, SD Paul, R Paliwal, T Satapathy
    Journal of Radiation Research and Applied Sciences, 16 (2), 100565 (2023)
  • Exploring Potential of Diacerein Nanogel for Topical Application in Arthritis: Formulation Development, QbD Based Optimization and Pre-Clinical Evaluation
    D Kesharwani, SD Paul, R Paliwal, T Satapathy
    Colloids and Surfaces B: Biointerfaces, 223, 113160 (2023)
  • Acaricidal Activity and Biochemical Analysis of Citrus limetta Seed Oil for Controlling Ixodid Tick Rhipicephalus microplus Infesting Cattle
    P Jain, T Satapathy, RK Pandey
    Systematic and Applied Acarology, 26 (7), 1350-1360 (2021)